ARK Investment Management LLC and Catherine D. Wood filed Amendment No. 3 to Schedule 13G with the SEC on November 13, 2026, disclosing beneficial ownership of 11,928,917 shares of Absci Corp common stock as of September 30, 2026.

Key Highlights

  • Aggregate beneficial ownership: ARK Investment Management LLC and Catherine D. Wood each reported beneficial ownership of 11,928,917 shares of Absci Corp common stock.
  • Percent of class: The 11,928,917 shares represent 6.95% of Absci Corp's outstanding common stock, according to the filing.
  • Voting and dispositive power split: ARK holds sole voting power and sole dispositive power over all 11,928,917 shares; Catherine D. Wood holds shared voting power and shared dispositive power over the same shares, with no sole authority.
  • Triggering date: The event requiring this filing occurred on September 30, 2026.
  • Notable client interest: The filing states that "ARK Genomic Revolution ETF, a series of a Delaware statutory trust," is the one ARK client with an interest in these securities exceeding 5 percent of the class.
  • Filers identified: ARK Investment Management LLC is organized in Delaware and classified as an investment adviser; Catherine D. Wood is a United States citizen, classified as a holding company and individual.

ARK and Wood Disclose Continued Position in Absci Corp Common Stock

According to Amendment No. 3 to Schedule 13G filed on November 13, 2026, ARK Investment Management LLC ("ARK") and Catherine D. Wood jointly reported a position of 11,928,917 shares of Absci Corp (NASDAQ:ABSI) common stock, representing 6.95% of the class. The filing identifies the triggering event date as September 30, 2026 and lists the CUSIP number for the shares as 00091E109.

The filing draws a clear distinction between the two reporting persons in terms of voting and dispositive control. ARK reported sole voting power and sole dispositive power over all 11,928,917 shares, with no shared authority. Catherine D. Wood, identified in the filing as Chief Executive Officer and Chief Investment Officer, reported shared voting power and shared dispositive power over the same 11,928,917 shares, and zero sole voting or dispositive power. No shares were reported as excluded from the aggregate amount in row 9 of the schedule.

Under Item 6 of the filing, ARK disclosed that no client currently holds an interest in the reported securities in excess of 5 percent "except ARK Genomic Revolution ETF, a series of a Delaware statutory trust." The filing further certifies, in accordance with standard Schedule 13G language, that the securities "were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer." The filing was signed by Kathleen Fontano, Chief Compliance Officer of ARK, and by Catherine D. Wood, both on November 13, 2026.

What Was Disclosed

ARK Investment Management LLC and Catherine D. Wood filed Amendment No. 3 to Schedule 13G reporting combined beneficial ownership of 11,928,917 shares, equal to 6.95% of Absci Corp's common stock, with the triggering date of September 30, 2026.